Thorsten Gräf

Stabilizing a Weak Binding State for Effectors in the Human Ras Protein by Cyclen Complexes

Ina C. Rosnizeck, Thorsten Gräf, Michael Spoerner et al. · Angewandte Chemie International Edition · 2010 · 108 citations

5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis

Akos Czibere, Ingmar Bruns, Nicolaus Kröger et al. · Bone Marrow Transplantation · 2009 · 107 citations

Hematological Malignancy, Oncology, Myelodysplastic Syndrome +7

Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma

Ulrich Steidl, Roland Fenk, Ingmar Bruns et al. · Bone Marrow Transplantation · 2004 · 82 citations · Full text

Cell Therapy, Pegylated G-csf, Immunology +16

Distinct molecular phenotype of malignant CD34+ hematopoietic stem and progenitor cells in chronic myelogenous leukemia

Ralf Kronenwett, Ulf Butterweck, Ulrich Steidl et al. · Oncogene · 2005 · 58 citations

Progenitor Cells, Distinct Molecular Phenotype, Hematological Malignancy +13

Comparative characterisation of thiamin diphosphate-dependent decarboxylases

Dörte Gocke, Thorsten Gräf, Helen Brosi et al. · Journal of Molecular Catalysis B Enzymatic · 2009 · 54 citations

Structure-function Enzyme Kinetics, Comparative Characterisation, Biochemistry